1. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis. Issue 9 (14th July 2022) Authors: Booijink, Richell; Salgado‐Polo, Fernando; Jamieson, Craig; Perrakis, Anastassis; Bansal, Ruchi Journal: EMBO molecular medicine Issue: Volume 14:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipoxygenases in chronic liver diseases: current insights and future perspectives. (March 2022) Authors: Heinrich, Lena; Booijink, Richell; Khurana, Amit; Weiskirchen, Ralf; Bansal, Ruchi Journal: Trends in pharmacological sciences Issue: Volume 43:Number 3(2022) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis. Issue 1 (20th February 2022) Authors: Kurniawan, Dhadhang Wahyu; Booijink, Richell; Jajoriya, Arun Kumar; Dhawan, Garima; Mishra, Divya; Oosterhuis, Dorenda; Argemi, Josepmaria; Storm, Gert; Olinga, Peter; Bataller, Ramon; Mohanty, Sujit Kumar; Mishra, Durga Prasad; Prakash, Jai; Bansal, Ruchi Journal: Clinical and translational discovery Issue: Volume 2:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗